Reply to Weatherald et al.: Pulmonary Vascular Resistance in Pulmonary Arterial Hypertension: La Pièce de Résistance?
- PMID: 33105086
- PMCID: PMC7885839
- DOI: 10.1164/rccm.202010-3834LE
Reply to Weatherald et al.: Pulmonary Vascular Resistance in Pulmonary Arterial Hypertension: La Pièce de Résistance?
Comment on
-
Risk Reduction and Hemodynamics with Initial Combination Therapy in Pulmonary Arterial Hypertension.Am J Respir Crit Care Med. 2021 Feb 15;203(4):484-492. doi: 10.1164/rccm.202004-1006OC. Am J Respir Crit Care Med. 2021. PMID: 32857597
-
Pulmonary Vascular Resistance in Pulmonary Arterial Hypertension: La Pièce de Résistance?Am J Respir Crit Care Med. 2021 Feb 15;203(4):524-525. doi: 10.1164/rccm.202009-3664LE. Am J Respir Crit Care Med. 2021. PMID: 33105080 Free PMC article. No abstract available.
References
-
- Badagliacca R, D’Alto M, Ghio S, Argiento P, Bellomo V, Brunetti ND, et al. Risk reduction and hemodynamics with initial combination therapy in pulmonary arterial hypertension. Am J Respir Crit Care Med. [online ahead of print] 28 Aug 2020. - PubMed
-
- van de Veerdonk MC, Kind T, Marcus JT, Mauritz G-J, Heymans MW, Bogaard H-J, et al. Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy. J Am Coll Cardiol. 2011;58:2511–2519. - PubMed
-
- Badagliacca R, Papa S, Manzi G, Miotti C, Luongo F, Sciomer S, et al. Usefulness of adding echocardiography of the right heart to risk-assessment scores in prostanoid-treated pulmonary arterial hypertension. JACC Cardiovasc Imaging. 2020;13:2054–2056. - PubMed
-
- Badagliacca R, Papa S, Matsubara H, Lang IM, Poscia R, Manzi G, et al. The importance of right ventricular evaluation in risk assessment and therapeutic strategies: raising the bar in pulmonary arterial hypertension. Int J Cardiol. 2020;301:183–189. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
